Outcome of long-term treatment with the 5α-reductase inhibitor finasteride in idiopathic hirsutism: Clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up

Fertility and Sterility

Volumn 66, Issue 5, 1996, Pages 734-740

  Castello, R ^a   Tosi, F ^a   Perrone, F ^a   Negri, C ^a   Muggeo, M ^a   Moghetti, P ^a  

^a MAGGIORE HOSPITAL   (Italy)

Author keywords

5 reductase; Finasteride; hirsutism

Indexed keywords

ANDROSTANEDIOL; ANDROSTANOLONE; FINASTERIDE; SEX HORMONE; STEROID; STEROID 5ALPHA REDUCTASE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; HIRSUTISM; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; LONG TERM CARE; METABOLITE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029859309     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0015-0282(16)58627-0     Document Type: Article

References (25)

1. R.S. Rittmaster Finasteride N Engl J Med 330 1994 120 125
2. P. Serafini R.A. Lobo Increased 5 α reductase activity in idiopathic hirsutism Fertil Steril 43 1985 74 78
3. K.D. Bingham D.A. Shaw The metabolism of testosterone by human male scalp skin J Endocrinol 57 1973 111 121
4. F. Fruzzetti D. De Lorenzo D. Parrini C. Ricci Effects of finasteride, a 5 α reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women J Clin Endocrinol Metab 79 1994 831 835
5. P. Moghetti R. Castello C.M. Magnani F. Tosi C. Negri D. Armanini Clinical and hormonal effects of the 5 α -reductase inhibitor finasteride in idiopathic hirsutism J Clin Endocrinol Metab 79 1994 1115 1121
6. I.L. Wong R.S. Morris L. Chang M. Spahn F.Z. Stanczyk R. Lobo A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women J Clin Endocrinol Metab 80 1995 233 238
7. L. Ciotta A. Cianci A.E. Calogero M.A. Palumbo E. Marietta A. Sciuto Clinical and endocrine effects of finasteride, a 5 α -reductase inhibitor, in women with idiopathic hirsutism Fertil Steril 64 1995 299 306
8. A.L. Dallob N.S. Sadick W. Unger S. Lipert L.A. Geissler S.L. Gregoire The effect of finasteride, a 5 α -reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness J Clin Endocrinol Metab 79 1994 703 706
9. X. Li C. Chen S.M. Singh F. Labrie The enzyme and inhibitors of 4-ene-3-oxosteroid 5 α -oxidoreductase Steroids 60 1995 430 441
10. E.P. Jenkins S. Andersson J. Imperato-McGinley J.D. Wilson D.W. Russell Genetic and pharmacological evidence for more than one human steroid 5 α -reductase J Clin Invest 89 1992 293 300
11. E.A. Thigpen I.R. Silver M.J. Guileyardo M. Linette Casey J. McConnell W.D. Russell Tissue distribution and ontogeny of steroid 5 α -reductase isoenzyme expression J Clin Invest 92 1993 903 910
12. J. Imperato-McGinley M. Miller J.W. Wilson R.E. Peterson C. Shackleton C. Gajdusek A cluster of male pseudohermaphrodites with 5 α -reductase deficiency in Papua New Guinea Clin Endocrinol (Oxf) 34 1991 293 298
13. M.D. Katz L. Cai Y. Zhu C. Herrera M. deFillo-Ricart C.H.L. Shackleton The biochemical and phenotypic characterization of females homozygous for 5 α -reductase-2 deficiency J Clin Endocrinol Metab 80 1995 3160 3167
14. R.B. Barnes R.L. Rosenfield S. Burstein D.A. Ehrmann Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome N Engl J Med 320 1989 559 565
15. R. Hatch R.L. Rosenfield M.H. Kim D. Tredway Hirsutism: implications, etiology, and management Am J Obstet Gynecol 140 1981 815 830
16. National Diabetes Data Group Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance Diabetes 28 1979 1039 1057
17. F. Kutten I. Mowszowicz G. Schaison P. Mauvais-Jarvis Androgen production and skin metabolism in hirsutism J Endocrinol 75 1977 83 91
18. L. Cusan A. Dupont J.-L. Gomez R.R. Tremblay F. Labrie Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial Fertil Steril 61 1994 281 287
19. P. Moghetti R. Castello C. Negri F. Tosi C.M. Magnani M.C. Fontanarosa Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior Fertil Steril 64 1995 511 517
20. R.S. Rittmaster Gonadotropin-releasing hormone (GnRH) agonists and estrogen/progestin replacement for the treatment of hirsutism: evaluating the results J Clin Endocrinol Metab 80 1995 3403 3405
21. 21 5 β /5 α metabolite ratios in subjects treated with the 5 α -reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5 α -reductase deficiency J Clin Endocrinol Metab 70 1990 777 782
22. J. Imperato-McGinley R.E. Peterson T. Gautier G. Cooper R. Daner A. Arthur Hormonal evaluation of a large kindred with complete androgen insensitivity: evidence for secondary 5 α -reductase deficiency J Clin Endocrinol Metab 54 1982 931 941
23. B. Couzinet G. Thomas J.C. Thalabard S. Brailly G. Schaison Effects of a pure antiandrogen on gonadotropin secretion in normal women and in polycystic ovarian disease Fertil Steril 52 1989 42 50
24. P. Dewis M.C. Newman D.C. Anderson Does testosterone affect the normal menstrual cycle? Clin Endocrinol (Oxf) 24 1986 515 521
25. E.D. Lephart K.J. Doody M.J. McPhaul E.R. Simpson Inverse relationship between ovarian aromatase cytochrome P450 and 5 alpha-reductase enzyme activities and mRNA levels during the estrous cycle in the rat J Steroid Biochem Mol Biol 42 1982 439 447